N
Nils Bögeholz
Researcher at University of Münster
Publications - 40
Citations - 318
Nils Bögeholz is an academic researcher from University of Münster. The author has contributed to research in topics: Atrial fibrillation & Sudden cardiac death. The author has an hindex of 10, co-authored 38 publications receiving 244 citations.
Papers
More filters
Journal ArticleDOI
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms.
Christian Pott,Adam Muszynski,Matthias Ruhe,Nils Bögeholz,Jan S. Schulte,Peter Milberg,Gerold Mönnig,Larissa Fabritz,Joshua I. Goldhaber,Günter Breithardt,Wilhelm Schmitz,Kenneth D. Philipson,Lars Eckardt,Paulus Kirchhof,Frank Müller +14 more
TL;DR: It is concluded that NCX overexpression is proarrhythmic in a non-failing environment even in the absence of reduced KV.
Journal ArticleDOI
Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model
Nils Bögeholz,Paul Pauls,B. Klemens Bauer,Jan S. Schulte,Dirk G. Dechering,Gerrit Frommeyer,Uwe Kirchhefer,Joshua I. Goldhaber,Frank Müller,Lars Eckardt,Christian Pott +10 more
TL;DR: This is the first study to demonstrate that genetic inhibition of NCX protects against afterdepolarizations and to investigate the underlying mechanisms.
Journal ArticleDOI
Direct comparison of the novel automated screening tool (AST) versus the manual screening tool (MST) in patients with already implanted subcutaneous ICD
Nils Bögeholz,Paul Pauls,Fatih Güner,Niklas Bode,Alicia Jeanette Fischer,Dirk G. Dechering,Gerrit Frommeyer,Julia Köbe,Kristina Wasmer,Lars Eckardt,Florian Reinke +10 more
TL;DR: The novel automated screening tool, introduced recently for objective screening, seems to be a valuable advance, due to its standardized and objective process, but it still lacks specificity.
Journal ArticleDOI
Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Gerrit Frommeyer,Magdalena Sterneberg,Dirk G. Dechering,Sven Kaese,Nils Bögeholz,Christian Pott,Michael Fehr,Harilaos Bogossian,Peter Milberg,Lars Eckardt +9 more
TL;DR: The antiarrhythmic effect could be explained by a significant increase in postrepolarization refractoriness as a result of a more marked increase in aERP as compared with aAPD.
Journal ArticleDOI
Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation.
Nils Bögeholz,Kevin Willy,Philipp Niehues,Benjamin Rath,Dirk G. Dechering,Gerrit Frommeyer,Simon Kochhäuser,A. Löher,Julia Köbe,Florian Reinke,Lars Eckardt +10 more
TL;DR: The S-ICD™ performance is promising even for many patients, who may not be 'classical' candidates for this technology, which sheds a spotlight on S- ICD™ therapy in recently discovered fields of indication beyond ideal preconditions.